Intellectual Property Watch was an independent newspaper that covered international IP policy from 2005-2019

Explore its archives with the menu or the link below.

Latest articles

Current R&D Causes High Prices In Drugs; New Model Needed To Make Drugs More Affordable, Speakers Say

Current R&D Causes High Prices In Drugs; New Model Needed To Make Drugs More Affordable, Speakers Say

Sinfah Tunsarawuth Feb 1, 2019 1 min read

BANGKOK – The current research and development model may encourage innovation in medicines, but has caused drugs to become unaffordable and inaccessible for people, particularly those in low- and middle-income…

Switzerland Receives Request For Compulsory Licence On Breast Cancer Drug

Catherine Saez Feb 1, 2019 1 min read

Swiss health activist group Public Eye yesterday requested the Swiss government to declare a compulsory licence for a Roche breast cancer treatment which the group says is unaffordable.

US Congressional Watchdog Launches Team For Sci/Tech Analysis

Beatrice Marone Jan 31, 2019 1 min read

A new chapter begins. The business of technology and science has been, and will increasingly be, the business of government: with this in mind, the US Government Accountability Office (GAO)…

WIPO Sheds Light On Artificial Intelligence Patenting Trends In New Report

WIPO Sheds Light On Artificial Intelligence Patenting Trends In New Report

Catherine Saez Jan 31, 2019 1 min read

The World Intellectual Property Organization today released its first report on artificial intelligence showing a sharp rise in patenting activities over the last few years. WIPO Director General Francis Gurry…

Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues

Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues

Catherine Saez Jan 30, 2019 1 min read

Shortages, faulty supply chains, unbearable prices, weak health systems – the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the…

Latest articles

WHO’s Access Roadmap And The Art Of Accommodation Of Pharma Interest

WHO’s Access Roadmap And The Art Of Accommodation Of Pharma Interest

The Roadmap to access to medicines, vaccines and other health products (Roadmap) to be discussed at this week's 144th session of WHO’s Executive Board accommodates vital interest of pharmaceutical TNC…

Read More
Open Access Advocates See End Of US Copyright Term Extension Act As Win For Commons

Open Access Advocates See End Of US Copyright Term Extension Act As Win For Commons

Open access advocates in the United States are celebrating the expiration, and non-renewal, of the Copyright Term Extension Act, which introduces into the public domain all works from 1923, and signal…

Read More
WHO Director Tedros: Innovation, Digital Health A Major Pillar In WHO Transformation

WHO Director Tedros: Innovation, Digital Health A Major Pillar In WHO Transformation

The World Health Organization is significantly upgrading its focus on digital health and innovation as it moves into a new era, renovating literally every aspect of the organisation, the WHO director …

Read More
India, Ecuador, Peru Bring TRIPS Flexibilities Into WHO Universal Health Coverage Discussions

India, Ecuador, Peru Bring TRIPS Flexibilities Into WHO Universal Health Coverage Discussions

Universal health coverage is a goal shared by all members of the World Health Organization. The ways to achieve that goal might however be based on different strategies. As members are working on a co…

Read More
US Complaints About Technology Transfer In China: Negotiating The Endgame

US Complaints About Technology Transfer In China: Negotiating The Endgame

Dean Pinkert writes: The United States Trade Representative (USTR) has been open about its view of the difficulties faced by US companies who claim – generally anonymously – that they have been forced…

Read More
US IP Law – Big Developments On The Horizon In 2019

US IP Law – Big Developments On The Horizon In 2019

The US started 2019 with a bang. Its Supreme Court has just announced a major patent decision, and more big developments could arrive in the coming months. Here are some of the top issues to watch thi…

Read More
1 9 10 11 12 13 1,213